October 13, 2021
Taiho Pharmaceutical on October 12 updated its supply outlook for the anticancer agent Abraxane IV Infusion 100 mg (paclitaxel), which is currently being subject to shipment restrictions, saying that the supply is expected to continue until mid-December in Japan without...read more